Home » Topics » Regulatory » Patents

Patents
RSS

New aldose reductase inhibitors designed in U.S.

Feb. 17, 2012

Pfizer presents novel candidate pain treatments

Feb. 16, 2012

Bristol-Myers Squibb develops new candidate cancer therapeutics

Feb. 16, 2012

New serotonin receptor antagonists patented in Japan

Feb. 16, 2012

Novel metabotropic glutamate mGlu4 receptor modulators identified

Feb. 16, 2012

EpiTherapeutics divulges new GASC-1 inhibitors

Feb. 16, 2012

Novel P13K inhibitors patented by Roche

Feb. 16, 2012

Addex Pharmaceuticals designs new modulators of metabotropic glutamate mGlu4 receptor

Feb. 15, 2012

Novartis announces new prostanoid IP1 receptor agonists

Feb. 15, 2012

Nippon Chemiphar patents new candidate therapies for urinary incontinence

Feb. 15, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...